|  | ENV1 | Background | B | G12 | | no | | | | 15.0 | 15.0 | 0.00 | | | | | 1.0 | 241 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Background | B | H12 | | no | | | | 15.0 | 15.0 | 0.00 | | | | | 1.0 | 175 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Standard | S1 | G1 | Standard1 | no | | | | 31618.0 | 31603.0 | 36.77 | >>14.30 | 500.00 | | | 1.0 | 200 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.12% |
|  | ENV1 | Standard | S1 | H1 | Standard1 | no | | | | 31670.0 | 31655.0 | 36.77 | >>14.30 | 500.00 | | | 1.0 | 231 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.12% |
|  | ENV1 | Standard | S2 | G2 | Standard1 | no | | | | 31253.0 | 31238.0 | 24.04 | 31.04 | 83.33 | 37 | | 1.0 | 227 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.08% |
|  | ENV1 | Standard | S2 | H2 | Standard1 | no | | | | 31287.0 | 31272.0 | 24.04 | 32.50 | 83.33 | 39 | | 1.0 | 224 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.08% |
|  | ENV1 | Standard | S3 | G3 | Standard1 | no | | | | 27102.0 | 27087.0 | 499.22 | 13.49 | 13.89 | 97 | | 1.0 | 221 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.82% |
|  | ENV1 | Standard | S3 | H3 | Standard1 | no | | | | 27808.0 | 27793.0 | 499.22 | 14.30 | 13.89 | 103 | | 1.0 | 184 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.82% |
|  | ENV1 | Standard | S4 | G4 | Standard1 | no | | | | 4577.0 | 4562.0 | 111.02 | 2.42 | 2.31 | 105 | | 1.0 | 214 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.47% |
|  | ENV1 | Standard | S4 | H4 | Standard1 | no | | | | 4420.0 | 4405.0 | 111.02 | 2.35 | 2.31 | 102 | | 1.0 | 228 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.47% |
|  | ENV1 | Standard | S5 | G5 | Standard1 | no | | | | 480.0 | 465.0 | 7.78 | 0.36 | 0.39 | 93 | | 1.0 | 178 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.60% |
|  | ENV1 | Standard | S5 | H5 | Standard1 | no | | | | 491.0 | 476.0 | 7.78 | 0.37 | 0.39 | 95 | | 1.0 | 219 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.60% |
|  | ENV1 | Standard | S6 | G6 | Standard1 | no | | | | 71.0 | 56.0 | 4.24 | 0.06 | 0.06 | 95 | | 1.0 | 229 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 5.73% |
|  | ENV1 | Standard | S6 | H6 | Standard1 | no | | | | 77.0 | 62.0 | 4.24 | 0.07 | 0.06 | 104 | | 1.0 | 182 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 5.73% |
|  | ENV1 | Standard | S7 | G7 | Standard1 | no | | | | 25.0 | 10.0 | 1.77 | 0.01 | 0.01 | 140 | | 1.0 | 186 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 6.73% |
|  | ENV1 | Standard | S7 | H7 | Standard1 | no | | | | 27.5 | 12.5 | 1.77 | 0.02 | 0.01 | 167 | | 1.0 | 196 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 6.73% |
|  | ENV1 | Standard | S8 | G8 | Standard1 | no | | | | 16.0 | 1.0 | 0.71 | 0.00 | 0.00 | 165 | | 1.0 | 177 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.29% |
|  | ENV1 | Standard | S8 | H8 | Standard1 | no | | | | 17.0 | 2.0 | 0.71 | 0.00 | 0.00 | 253 | | 1.0 | 210 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.29% |
|  | ENV1 | Standard | S9 | G9 | Standard1 | no | | | | 13.0 | -2.0 | 0.00 | <<0.06 | 0.00 | | | 1.0 | 186 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Standard | S9 | H9 | Standard1 | no | | | | 13.0 | -2.0 | 0.00 | <<0.06 | 0.00 | | | 1.0 | 229 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Standard | S10 | G10 | Standard1 | no | | | | 15.0 | 0.0 | 1.41 | 0.00 | 0.00 | 2386 | | 1.0 | 163 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 10.10% |
|  | ENV1 | Standard | S10 | H10 | Standard1 | no | | | | 13.0 | -2.0 | 1.41 | <<0.06 | 0.00 | | | 1.0 | 185 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 10.10% |
|  | ENV1 | Control | C1 | G11 | IH5672 | no | | | | 45.0 | 30.0 | 0.00 | 18.28 | 0.00 | | | 500.0 | 174 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Control | C1 | H11 | IH5672 | no | | | | 45.0 | 30.0 | 0.00 | 18.28 | 0.00 | | | 500.0 | 232 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X1 | A1 | 111 | yes | | | | 22.0 | 7.0 | 3.54 | 2.26 | | | | 200.0 | 215 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 18.13% |
|  | ENV1 | Unknown | X1 | B1 | 111 | yes | | | | 17.0 | 2.0 | 3.54 | 0.90 | | | | 200.0 | 203 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 18.13% |
|  | ENV1 | Unknown | X2 | A2 | 112 | no | | | | 68.0 | 53.0 | 1.41 | 11.71 | | | | 200.0 | 231 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.11% |
|  | ENV1 | Unknown | X2 | B2 | 112 | no | | | | 66.0 | 51.0 | 1.41 | 11.34 | | | | 200.0 | 232 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.11% |
|  | ENV1 | Unknown | X3 | A3 | 113 | no | | | | 33.0 | 18.0 | 0.71 | 4.81 | | | | 200.0 | 202 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.11% |
|  | ENV1 | Unknown | X3 | B3 | 113 | no | | | | 34.0 | 19.0 | 0.71 | 5.03 | | | | 200.0 | 211 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.11% |
|  | ENV1 | Unknown | X4 | A4 | 114 | no | | | | 557.0 | 542.0 | 7.07 | 81.47 | | | | 200.0 | 183 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.28% |
|  | ENV1 | Unknown | X4 | B4 | 114 | no | | | | 547.0 | 532.0 | 7.07 | 80.21 | | | | 200.0 | 223 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.28% |
|  | ENV1 | Unknown | X5 | A5 | 115 | no | | | | 19.0 | 4.0 | 0.71 | 1.47 | | | | 200.0 | 213 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.82% |
|  | ENV1 | Unknown | X5 | B5 | 115 | no | | | | 18.0 | 3.0 | 0.71 | 1.20 | | | | 200.0 | 206 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.82% |
|  | ENV1 | Unknown | X6 | A6 | 116 | no | | | | 117.5 | 102.5 | 0.35 | 20.26 | | | | 200.0 | 172 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.30% |
|  | ENV1 | Unknown | X6 | B6 | 116 | no | | | | 118.0 | 103.0 | 0.35 | 20.35 | | | | 200.0 | 225 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.30% |
|  | ENV1 | Unknown | X7 | A7 | 117 | no | | | | 20.0 | 5.0 | 0.71 | 1.74 | | | | 200.0 | 231 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.63% |
|  | ENV1 | Unknown | X7 | B7 | 117 | no | | | | 19.0 | 4.0 | 0.71 | 1.47 | | | | 200.0 | 170 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.63% |
|  | ENV1 | Unknown | X8 | A8 | 118 | no | | | | 276.0 | 261.0 | 4.60 | 44.22 | | | | 200.0 | 217 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.65% |
|  | ENV1 | Unknown | X8 | B8 | 118 | no | | | | 282.5 | 267.5 | 4.60 | 45.13 | | | | 200.0 | 196 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.65% |
|  | ENV1 | Unknown | X9 | A9 | 119 | no | | | | 30.0 | 15.0 | 0.71 | 4.15 | | | | 200.0 | 155 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.32% |
|  | ENV1 | Unknown | X9 | B9 | 119 | no | | | | 31.0 | 16.0 | 0.71 | 4.37 | | | | 200.0 | 189 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.32% |
|  | ENV1 | Unknown | X10 | A10 | 120 | no | | | | 186.0 | 171.0 | 3.18 | 31.06 | | | | 200.0 | 189 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.73% |
|  | ENV1 | Unknown | X10 | B10 | 120 | no | | | | 181.5 | 166.5 | 3.18 | 30.37 | | | | 200.0 | 196 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.73% |
|  | ENV1 | Unknown | X11 | A11 | 121 | no | | | | 30.0 | 15.0 | 0.00 | 4.15 | | | | 200.0 | 194 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X11 | B11 | 121 | no | | | | 30.0 | 15.0 | 0.00 | 4.15 | | | | 200.0 | 201 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X12 | A12 | 122 | no | | | | 25.0 | 10.0 | 0.35 | 3.00 | | | | 200.0 | 187 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.40% |
|  | ENV1 | Unknown | X12 | B12 | 122 | no | | | | 25.5 | 10.5 | 0.35 | 3.11 | | | | 200.0 | 196 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.40% |
|  | ENV1 | Unknown | X13 | C1 | 123 | no | | | | 18.0 | 3.0 | 0.71 | 1.20 | | | | 200.0 | 178 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.04% |
|  | ENV1 | Unknown | X13 | D1 | 123 | no | | | | 17.0 | 2.0 | 0.71 | 0.90 | | | | 200.0 | 203 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.04% |
|  | ENV1 | Unknown | X14 | C2 | 124 | no | | | | 259.0 | 244.0 | 0.00 | 41.80 | | | | 200.0 | 201 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X14 | D2 | 124 | no | | | | 259.0 | 244.0 | 0.00 | 41.80 | | | | 200.0 | 197 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X15 | C3 | 125 | no | | | | 30.0 | 15.0 | 0.00 | 4.15 | | | | 200.0 | 208 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X15 | D3 | 125 | no | | | | 30.0 | 15.0 | 0.00 | 4.15 | | | | 200.0 | 241 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X16 | C4 | 126 | no | | | | 35.0 | 20.0 | 0.35 | 5.24 | | | | 200.0 | 215 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.02% |
|  | ENV1 | Unknown | X16 | D4 | 126 | no | | | | 34.5 | 19.5 | 0.35 | 5.14 | | | | 200.0 | 178 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.02% |
|  | ENV1 | Unknown | X17 | C5 | 127 | no | | | | 26.0 | 11.0 | 1.41 | 3.23 | | | | 200.0 | 212 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 5.66% |
|  | ENV1 | Unknown | X17 | D5 | 127 | no | | | | 24.0 | 9.0 | 1.41 | 2.75 | | | | 200.0 | 215 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 5.66% |
|  | ENV1 | Unknown | X18 | C6 | 128 | no | | | | 108.5 | 93.5 | 2.47 | 18.77 | | | | 200.0 | 182 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.32% |
|  | ENV1 | Unknown | X18 | D6 | 128 | no | | | | 105.0 | 90.0 | 2.47 | 18.18 | | | | 200.0 | 207 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.32% |
|  | ENV1 | Unknown | X19 | C7 | 129 | no | | | | 24.0 | 9.0 | 1.41 | 2.75 | | | | 200.0 | 233 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 6.15% |
|  | ENV1 | Unknown | X19 | D7 | 129 | no | | | | 22.0 | 7.0 | 1.41 | 2.26 | | | | 200.0 | 223 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 6.15% |
|  | ENV1 | Unknown | X20 | C8 | 130 | no | | | | 58.0 | 43.0 | 0.00 | 9.85 | | | | 200.0 | 223 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X20 | D8 | 130 | no | | | | 58.0 | 43.0 | 0.00 | 9.85 | | | | 200.0 | 198 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.00% |
|  | ENV1 | Unknown | X21 | C9 | 131 | no | | | | 24.0 | 9.0 | 2.12 | 2.75 | | | | 200.0 | 223 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 9.43% |
|  | ENV1 | Unknown | X21 | D9 | 131 | no | | | | 21.0 | 6.0 | 2.12 | 2.01 | | | | 200.0 | 191 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 9.43% |
|  | ENV1 | Unknown | X22 | C10 | 132 | no | | | | 16.0 | 1.0 | 0.71 | 0.59 | | | | 200.0 | 211 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.29% |
|  | ENV1 | Unknown | X22 | D10 | 132 | no | | | | 17.0 | 2.0 | 0.71 | 0.90 | | | | 200.0 | 181 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.29% |
|  | ENV1 | Unknown | X23 | C11 | 133 | no | | | | 23.5 | 8.5 | 0.35 | 2.63 | | | | 200.0 | 200 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.52% |
|  | ENV1 | Unknown | X23 | D11 | 133 | no | | | | 23.0 | 8.0 | 0.35 | 2.51 | | | | 200.0 | 219 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.52% |
|  | ENV1 | Unknown | X24 | C12 | 134 | no | | | | 25.0 | 10.0 | 1.41 | 3.00 | | | | 200.0 | 162 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 5.89% |
|  | ENV1 | Unknown | X24 | D12 | 134 | no | | | | 23.0 | 8.0 | 1.41 | 2.51 | | | | 200.0 | 235 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 5.89% |
|  | ENV1 | Unknown | X25 | E1 | 135 | no | | | | 19.0 | 4.0 | 0.71 | 1.47 | | | | 200.0 | 206 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.82% |
|  | ENV1 | Unknown | X25 | F1 | 135 | no | | | | 18.0 | 3.0 | 0.71 | 1.20 | | | | 200.0 | 243 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.82% |
|  | ENV1 | Unknown | X26 | E2 | 136 | no | | | | 1421.5 | 1406.5 | 39.24 | 180.97 | | | | 200.0 | 228 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.82% |
|  | ENV1 | Unknown | X26 | F2 | 136 | no | | | | 1366.0 | 1351.0 | 39.24 | 174.97 | | | | 200.0 | 182 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 2.82% |
|  | ENV1 | Unknown | X27 | E3 | 137 | no | | | | 17.0 | 2.0 | 1.41 | 0.90 | | | | 200.0 | 205 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 7.86% |
|  | ENV1 | Unknown | X27 | F3 | 137 | no | | | | 19.0 | 4.0 | 1.41 | 1.47 | | | | 200.0 | 193 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 7.86% |
|  | ENV1 | Unknown | X28 | E4 | 138 | no | | | | 195.5 | 180.5 | 1.41 | 32.49 | | | | 200.0 | 190 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.73% |
|  | ENV1 | Unknown | X28 | F4 | 138 | no | | | | 193.5 | 178.5 | 1.41 | 32.19 | | | | 200.0 | 194 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.73% |
|  | ENV1 | Unknown | X29 | E5 | 139 | no | | | | 20.0 | 5.0 | 0.71 | 1.74 | | | | 200.0 | 192 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.45% |
|  | ENV1 | Unknown | X29 | F5 | 139 | no | | | | 21.0 | 6.0 | 0.71 | 2.01 | | | | 200.0 | 180 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.45% |
|  | ENV1 | Unknown | X30 | E6 | 140 | no | | | | 21.0 | 6.0 | 0.71 | 2.01 | | | | 200.0 | 257 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.29% |
|  | ENV1 | Unknown | X30 | F6 | 140 | no | | | | 22.0 | 7.0 | 0.71 | 2.26 | | | | 200.0 | 192 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.29% |
|  | ENV1 | Unknown | X31 | E7 | 141 | no | | | | 17.0 | 2.0 | 0.71 | 0.90 | | | | 200.0 | 201 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.29% |
|  | ENV1 | Unknown | X31 | F7 | 141 | no | | | | 16.0 | 1.0 | 0.71 | 0.59 | | | | 200.0 | 226 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.29% |
|  | ENV1 | Unknown | X32 | E8 | 142 | no | | | | 156.0 | 141.0 | 2.12 | 26.44 | | | | 200.0 | 203 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.37% |
|  | ENV1 | Unknown | X32 | F8 | 142 | no | | | | 153.0 | 138.0 | 2.12 | 25.97 | | | | 200.0 | 165 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 1.37% |
|  | ENV1 | Unknown | X33 | E9 | 143 | no | | | | 17.0 | 2.0 | 1.41 | 0.90 | | | | 200.0 | 184 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 7.86% |
|  | ENV1 | Unknown | X33 | F9 | 143 | no | | | | 19.0 | 4.0 | 1.41 | 1.47 | | | | 200.0 | 203 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 7.86% |
|  | ENV1 | Unknown | X34 | E10 | 144 | no | | | | 407.0 | 392.0 | 18.03 | 62.13 | | | | 200.0 | 180 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.57% |
|  | ENV1 | Unknown | X34 | F10 | 144 | no | | | | 381.5 | 366.5 | 18.03 | 58.73 | | | | 200.0 | 172 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 4.57% |
|  | ENV1 | Unknown | X35 | E11 | 145 | no | | | | 49.0 | 34.0 | 4.24 | 8.11 | | | | 200.0 | 223 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 9.22% |
|  | ENV1 | Unknown | X35 | F11 | 145 | no | | | | 43.0 | 28.0 | 4.24 | 6.91 | | | | 200.0 | 226 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 9.22% |
|  | ENV1 | Unknown | X36 | E12 | 146 | no | | | | 45.5 | 30.5 | 3.18 | 7.41 | | | | 200.0 | 188 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 6.66% |
|  | ENV1 | Unknown | X36 | F12 | 146 | no | | | | 50.0 | 35.0 | 3.18 | 8.31 | | | | 200.0 | 231 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 6.66% |
|  | ENV2 | Background | B | G12 | | no | | | | 11.0 | 11.0 | 0.35 | | | | | 1.0 | 145 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.14% |
|  | ENV2 | Background | B | H12 | | no | | | | 11.5 | 11.5 | 0.35 | | | | | 1.0 | 104 | | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 3.14% |
|  | ENV2 | Standard | S1 | G1 | Standard1 | no | | | | 31755.5 | 31744.2 | 76.72 | >>14.26 | 500.00 | | | 1.0 | 114 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.24% |
|  | ENV2 | Standard | S1 | H1 | Standard1 | no | | | | 31647.0 | 31635.8 | 76.72 | >>14.26 | 500.00 | | | 1.0 | 149 | Standard1 | | | | false | | | | | 02-14A22-IgA-Biotin.srbx | 2011-06-21 13:50 | LX10011084403 | 02-14A22 | 687.42 | 16357 | SampleInfo | HIV Disease Progression - Demo Study | Human | LabKey | BioPlex | 0.24% |